Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Boehringer Ingelheim
AstraZeneca
Mallinckrodt
McKinsey

Last Updated: November 20, 2019

DrugPatentWatch Database Preview

Invagen Pharms Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for INVAGEN PHARMS, and what generic and branded alternatives to INVAGEN PHARMS drugs are available?

INVAGEN PHARMS has fifty-six approved drugs.

There is one tentative approval on INVAGEN PHARMS drugs.

Summary for Invagen Pharms
US Patents:0
Tradenames:46
Ingredients:46
NDAs:56

Drugs and US Patents for Invagen Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Invagen Pharms ZONISAMIDE zonisamide CAPSULE;ORAL 077869-003 May 31, 2006 AB RX No No   Start Trial   Start Trial
Invagen Pharms WARFARIN SODIUM warfarin sodium TABLET;ORAL 090935-006 May 25, 2011 AB RX No No   Start Trial   Start Trial
Invagen Pharms NAPROXEN naproxen TABLET, DELAYED RELEASE;ORAL 091432-002 Sep 19, 2011 AB RX No No   Start Trial   Start Trial
Invagen Pharms RIZATRIPTAN BENZOATE rizatriptan benzoate TABLET;ORAL 204339-001 Jul 1, 2013 AB RX No No   Start Trial   Start Trial
Invagen Pharms ESCITALOPRAM OXALATE escitalopram oxalate TABLET;ORAL 078604-002 Sep 11, 2012 AB RX No No   Start Trial   Start Trial
Invagen Pharms LURASIDONE HYDROCHLORIDE lurasidone hydrochloride TABLET;ORAL 208028-004 Jan 3, 2019 DISCN No No   Start Trial   Start Trial
Invagen Pharms FENOFIBRATE (MICRONIZED) fenofibrate CAPSULE;ORAL 207378-003 Mar 28, 2017 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Dow
Medtronic
Moodys
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.